Sg Americas Securities, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Sg Americas Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$17.63 - $21.74 $25,299 - $31,196	1,435 Added 8.1%	19,160 $378,000
Q4 2023 Jan 12, 2024	BUY	$14.37 - $19.07 $254,708 - $338,015	17,725 New	17,725 $311,000
Q1 2023 Apr 28, 2023	BUY	$10.7 - $15.79 $167,123 - $246,624	15,619 New	15,619 $168,000
Q4 2021 Feb 07, 2022	SELL	$10.39 - $15.15 $192,744 - $281,047	-18,551 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$11.39 - $16.23 $211,295 - $301,082	18,551 New	18,551 $211,000
Q2 2021 Aug 12, 2021	SELL	$13.22 - $19.09 $75,274 - $108,698	-5,694 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$16.68 - $23.97 $94,975 - $136,485	5,694 New	5,694 $105,000
Q4 2020 Feb 04, 2021	SELL	$14.8 - $21.15 $1.4 Million - $2 Million	-94,543 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$15.21 - $25.53 $856,688 - $1.44 Million	56,324 Added 147.37%	94,543 $1.45 Million
Q2 2020 Jul 20, 2020	BUY	$15.08 - $26.0 $576,342 - $993,694	38,219 New	38,219 $974,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.